Five open questions across AI funding, model timing, and Boston roster calls.
Bloomberg says Irregular, founded by former Anthropic staffers, is discussing a new round at a $5 billion value. The company has not announced a closed deal or final terms.
The talks show how much investors may pay for AI safety tools. A deal could raise the price for every startup selling agent security.
Bloomberg reports that Modal Labs is in talks to raise money at a $15 billion value. Reuters says the company did not answer its request for comment, so the round remains open.
Modal sells the computing layer behind many AI products. A deal this rich would keep pressure on builder costs and rival platforms.
Reuters says Anthropic is considering another model release before a possible stock sale. The company has not confirmed the model, its name, or a launch date.
A surprise release could reset model tests and pricing before Anthropic asks public investors to buy in. Builders should wait for real access details.
The Boston Globe says the Bruins top two lines are taking shape in camp. Injuries and the last roster battles could still change the opening night group.
The final mix will set early roles for Boston's young players. It will also show whether the club values speed or safer veteran depth.
MLB.com says Red Sox prospect Braiden Ward helped his case with a five-hit game for Worcester. Boston has not named its playoff roster, and the final bench spots remain open.
Ward would add speed and another late-game option. Choosing him would also push a more experienced player out of the final group.